A new biotechnology start-up focused on the development of an universal Human Papillomavirus (HPV) vaccine to provide prophylaxis against all HPV-related cancers and diseases. Our pilot vaccine, RGVax, promises to provide protection against all 15 oncogenic HPVs and many others that cause various warts.